Magnetic resonance imaging and spectroscopy in Fukuyama-type congenital muscular dystrophy

Journal of Pediatric Neurology

Volumn 4, Issue 4, 2006, Pages 261-264

  Kato, Zenichiro ^a,b,c   Saito, Kayoko ^d   Isogai, Koji ^a   Kondo, Naomi ^a,b  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c HARVARD UNIVERSITY   (United States)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Fukuyama type congenital muscular dystrophy; Magnetic resonance imaging; Spectroscopy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLINE; CREATINE KINASE; FRUCTOSE BISPHOSPHATE ALDOLASE; INOSITOL; LACTATE DEHYDROGENASE; MEROSIN; N ACETYLASPARTIC ACID;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; FRONTAL LOBE; FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY; HAPLOTYPE; HUMAN; INFANT; MALE; MENTAL DEFICIENCY; MICROGYRIA; MUSCLE HYPOTONIA; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PACHYGYRIA; SIMULATION; WHITE MATTER;

EID: 33845518713     PISSN: 13042580     EISSN: 18759041     Source Type: Journal    
DOI: 10.1055/s-0035-1557340     Document Type: Article

References (11)

1. Y. Fukuyama, M. Osawa and H. Suzuki, Congenital progressive muscular dystrophy of the Fukuyama type: Clinical, genetic and pathologic considerations, Brain Dev 3 (1981), 1-29.
2. N. Aida, K. Tamagawa, K. Takada et al., Brain MR in Fukuyama congenital muscular dystrophy, AJNR Am J Neuroradiol 17 (1996), 605-613.
3. M. Aslan, A. Alkan, C. Yakinci, E. Sonmezgoz, U. Bicak and S. Zorludemir, Merosin-negative congenital muscular dystrophy: Magnetic resonance spectroscopy findings, Brain Dev 27 (2005), 308-310.
4. C.C. Leite, U.C. Reed, M.C. Otaduy et al., Congenital muscular dystrophy with merosin deficiency: 1H MR spectroscopy and diffusion-weighted MR imaging, Radiology 235 (2005), 190-196.
5. K.Kobayashi, Y. Nakahori, M. Miyake et al., An ancient retro-transposal insertion causes Fukuyama-type congenital muscular dystrophy, Nature 394 (1998), 388-392.
6. E.R. Danielsen and B. Ross, Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases, (3rd ed.), New York: Marcell Dekker, 1999.
7. T. Toda, K. Kobayashi, S. Takeda et al., Fukuyama-type congenital muscular dystrophy (FCMD) and alpha-dystroglycanopathy, Congenit Anom (Kyoto) 43 (2003), 97-104.
8. D.E. Michele and K.P. Campbell, Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function, J Biol Chem 278 (2003), 15457-15460.
9. C. Longman, M. Brockington, S. Torelli et al., Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan, Hum Mol Genet 12 (2003), 2853-2861.
10. R.N. Sener, Diffusion magnetic resonance imaging patterns in metabolic and toxic brain disorders, Acta Radiol 45 (2004), 561-570.
11. H. Kurahashi, M. Taniguchi, C. Meno et al., Basement membrane fragility underlies embryonic lethality in fukutin-null mice, Neurobiol Dis 19 (2005), 208-217.